Clinical Trials at Drexel Medicine
Drexel University College of Medicine's clinical research program seeks to improve patient care through innovative approaches and new findings. By evaluating medicines, therapies and diagnostic tools, clinical research drives discoveries in health promotion and disease prevention to improve health.
Research Solutions Committee for Clinical Research
The Office of the Vice Dean for Research is launching a Research Solutions Committee. The goal is to give clinical researchers an opportunity to address concerns and issues with their clinical research projects. Learn more.
Open Clinical Trials
- REVERSE: The REVERSE Clnical Study will evaluate the effects of obeticholic acid in patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH). Learn more.
- REGENERATE Clinical Study: The Drexel Center for Liver, Biliary and Pancreatic Diseases is running a clinical study to evaluate the effects of obeticholic acid (OCA) on improvement in nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease. Learn more.
- CONFIRM Clinical Trial: Drexel Gastroenterology & Hepatology is running a clinical study evaluating the use of terlipressin for the treatment of Hepatorenal Syndrome (HRS) type 1. Learn more.
- Resolve-IT: Clinical trial will evaluate the efficacy of elafibranor on the resolution of nonalcoholic steatohepatitis (NASH), a form of nonalcoholic fatty liver disease. Learn more.
- RESTORE: A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy Learn more.
- INSYTE: Management of Parkinson's Disease Psychosis in Actual Practice Learn more.
- Epidemiology of Asthma: Clinical studies include the epidemiology of asthma, particularly in Philadelphia's high-risk urban population, emergency care of asthma patients, and the natural history of asthma treatments and outcomes. Learn more.
- Phase II ‐ HCC Biomarker Study: The goal of the HCC Biomarker study is to develop a diagnostic blood test that can identify liver cancer in its early stages and predict liver cancer recurrence after surgical resection. Learn more.
Back to Top